Subtitle
Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Subtitle
Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Proto therapy Time
March 2024
Executive summary
This review included 10 studies representing 1,718 patients. A pooled analysis was performed to evaluate the relationship between lymphopenia and overall survival for glioblastoma (GBM) patients treated with chemotherapy and RT. The mean overall pooled incidence of lymphopenia for all studies was 31.8%. Lymphopenia was associated with increased risk of death, highlighting lymphopenia as a poor prognostic factor in GBM patients.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
March 2024
A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry.
Proton Therapy Publication
April 2024
A bibliometric analysis of cardiotoxicity in cancer radiotherapy.
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
Proton Therapy Publication
March 2024
A systematic review and meta-analysis of radiotherapy and particle beam therapy for skull base chondrosarcoma: TRP-chondrosarcoma 2024.
Proton Therapy Publication
March 2024
Evidence for external beam radiotherapy in mediastinal Hodgkin and non-Hodgkin lymphoma - systematic review.
Proton Therapy Publication
April 2024
Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
Proton Therapy Publication
October 2023
Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.
Proton Therapy Publication
August 2023
Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
Proton Therapy Publication
April 2023
Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.